Search
Find a recruiting study
7,120 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 26, 2026). No sign-up needed.
Most recently updated studies · page 48 of 297
- RecruitingPhase 3
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
AstraZeneca
- Location
- Phoenix, AZ + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
AbbVie
- Location
- Carlsbad, CA + 17 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
Rademikibart IV for Acute Asthma and COPD Exacerbation
Connect Biopharm LLC
- Location
- Miami, FL + 1 other US site
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
Biogen
- Location
- Glendale, AZ + 10 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Evaluation of Orthokeratology Lenses With a 5MM Optic Zone Diameter
CooperVision International Limited (CVIL)
- Location
- Pleasanton, CA + 1 other US site
- Eligibility basics
- Ages 7–35
- RecruitingPhase 1/Phase 2
A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage
Astellas Pharma Global Development, Inc.
- Location
- Boston, MA
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
Pfizer
- Location
- Bryant, AR + 11 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury
NervGen Pharma
- Location
- Stamford, CT + 1 other US site
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Pelage Pharmaceuticals, Inc.
- Location
- Birmingham, AL + 26 other US sites
- Eligibility basics
- Ages 18–55 · Men only
- Recruiting
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With…
LivaNova
- Location
- Birmingham, AL + 49 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
EFS of the DUO System for Tricuspid Regurgitation
CroiValve Limited
- Location
- Phoenix, AZ + 12 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions
RapidPulse, Inc
- Location
- Torrance, CA + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 1/Phase 2
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Regeneron Pharmaceuticals
- Location
- Phoenix, AZ + 16 other US sites
- Eligibility basics
- Ages 2+ · Men only
- RecruitingPhase 3
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Location
- Phoenix, AZ + 19 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Prevail Global Study
Medtronic Vascular
- Location
- Birmingham, AL + 53 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Janus II Feasibility
Zoll Medical Corporation
- Location
- Scottsdale, AZ + 3 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
AstraZeneca
- Location
- Birmingham, AL + 151 other US sites
- Eligibility basics
- Ages 40+
- Recruiting
Evaluation of a Switchable Acrylic Adhesive Drape for Safer Removal in Negative Pressure Wound Therapy Applications.
Global Biomedical Technologies, LLC
- Location
- Los Angeles, CA + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
Clear Scientific, Inc.
- Location
- Glendale, CA
- Eligibility basics
- Ages 18–55
- RecruitingPhase 1/Phase 2
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
Sumitomo Pharma America, Inc.
- Location
- La Jolla, CA + 2 other US sites
- Eligibility basics
- Ages 40–72
- Recruiting
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Stryker Neurovascular
- Location
- Tucson, AZ + 19 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Laboratoires Thea
- Location
- San Francisco, CA + 3 other US sites
- Eligibility basics
- Ages 6+
- RecruitingPhase 3
Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy
Vertanical GmbH
- Location
- Mobile, AL + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Los Angeles, CA + 9 other US sites
- Eligibility basics
- Ages 4+
Data source: deploy-time snapshot of the ClinicalTrials.gov API. How we list studies